BluGlass (ASX: BLG) has secured a significant A$1.25 million development program with a US Tier-1 defence prime, validating its GaN laser technology.
The customer supplies advanced systems across commercial, military, and business aviation sectors.
The program involves custom development of packaged visible GaN DFB lasers and gain chip components to be integrated as a laser + optical amplifier.
The total program is expected to run for 14-20 months, with payments linked to technical milestones.
Initial A$560k Order Received
An initial order of A$560k (US$390k) has been received, covering the first 7-9 months of the program.
This order validates the demand for BluGlass’s GaN laser technology.
The second phase of the program is contingent on the successful delivery of milestones from the first phase, providing a clear pathway for ongoing collaboration.
This win strengthens BluGlass’s U.S. manufacturing footprint, while also solidifying its relationship with the CLAWS Hub for regulatory approvals and positioning the company more firmly within the critical US defence supply chain.
The company sees potential for follow-on development and long-term product revenues beyond the initial program. This move .
Annual Report Highlights
In its FY25 results, BluGlass reported revenue and income of A$11.7 million.
The company noted a project pipeline exceeding US$100 million from 29 active opportunities.
BluGlass also highlighted a world-record single-mode GaN laser performance at 1250 mW.
The company continues to make progress in DFB/SC lasers and MOPA technology.
A A$7.6 million capital raise was completed in FY25 to fund production and working capital.
BluGlass's Defence Deal and Future Outlook
The A$1.25 million defence program, underpinned by an initial A$560k order, represents a significant validation for BluGlass’s GaN laser technology and its US manufacturing strategy.
While execution risks and the long conversion cycle of large defence contracts remain, this deal provides near-term revenue and a pathway to future product sales, aligning with the company’s broader project-to-product strategy.
